Zusammenfassung
Das Scleroedema adultorum (SA) ist eine seltene skleromuzinöse Erkrankung nicht geklärter Ätiologie, die charakteristischerweise zu brettharten Indurationen im Bereich des Nackens und oberen Rumpfes führt. Drei Typen des SA werden entsprechend ihrer Assoziation zu vorbestehenden bzw. zugrunde liegenden Erkrankungen unterschieden: SA bei Infektionen (v. a. Streptokokkeninfektionen der oberen Atemwege), SA bei monoklonaler Gammopathie und SA bei Diabetes mellitus. Die klinische Ausprägung, Schwere der Erkrankung und Verlauf variieren je nach Subtyp stark. Es existieren bisher keine evidenzbasierten Therapiestandards für das SA. Während spontane Remissionen häufig bei Infekt-assoziierten Formen des SA auftreten, kommt es beim SA im Rahmen von Diabetes mellitus oder monoklonaler Gammopathie in der Regel zu einem chronisch progredienten Verlauf. Zu den derzeitig empfohlenen Erstlinientherapien zählen Phototherapie und Methotrexat, eine klinische Besserung zeigt sich oftmals aber erst nach mehreren Monaten, und Therapieversagen ist häufig. Ergänzend sollte bei allen Formen des SA auch eine Physiotherapie zur Verbesserung der Beweglichkeit erfolgen.
Abstract
Scleredema adultorum (SA) is a rare scleromucinous disease of unknown etiology that characteristically leads to wodden induration located on the neck and upper trunk. Three types of SA can be distinguished according to the association with pre-existing or underlying disease: SA in association with infections (mostly streptococcal infections of the upper respiratory tract), SA in association with monoclonal gammopathy, and SA in association with diabetes. The clinical findings, extent of disease, and course substantially differ depending on the subtype of SA. Spontaneous regression often occurs in infection-associated SA, whereas patients with diabetes or monoclonal gammopathy usually show a chronic progressive course of disease. Phototherapy and methotrexate are the current recommended first-line treatments for SA, clinical improvement often takes several months, and treatment failure is frequent. Physiotherapy should be offered in all types of SA in order to improve motility.
Literatur
Buschke A (1902) Ueber Skleroedem. Berl Klin Wochenschr 39:955–957
Greenberg LM, Geppert C, Worthen HG, Good RA (1963) Scleredema „adultorum“ in children. Report of three cases with histochemical study and review of world literature. Pediatrics 32:1044–1054
Knobler R, Moinzadeh P, Hunzelmann N et al (2017) European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis. J Eur Acad Dermatol Venereol 31:1581–1594
Cole GW, Headley J, Skowsky R (1983) Scleredema diabeticorum: a common and distinct cutaneous manifestation of diabetes mellitus. Diabetes Care 6:189–192
Haustein UF (1999) Scleroderma-like lesions in insulin-dependent diabetes mellitus. J Eur Acad Dermatol Venereol 13:50–53
Kirschke J, Kreuter A (2014) Scleroedema adultorum – Eine Übersicht. Akt Dermatol 40:171–176
Boin F, Hummers LK (2008) Scleroderma-like fibrosing disorders. Rheum Dis Clin North Am 34:199–220
Isaac A, Costa I, Leal I (2010) Scleredema of Buschke in a child with cardiac involvement. Pediatr Dermatol 27:315–317
Ioannidou DI, Krasagakis K, Stefanidou MP et al (2005) Scleredema adultorum of Buschke presenting as periorbital edema: a diagnostic challenge. J Am Acad Dermatol 52:41–44
Paz RA, Badra RE, Martí HM, Maxit MJ (1998) Systemic Buschke’s scleredema with cardiomyopathy, monoclonal IgG kappa gammopathy and amyloidosis. Case report with autopsy. Medicina (B Aires) 58:501–503
Cole HG, Winkelmann RK (1990) Acid mucopolysaccharide staining in scleredema. J Cutan Pathol 17:211–213
Rimon D, Lurie M, Storch S et al (1988) Cardiomyopathy and multiple myeloma. Complications of scleredema adultorum. Arch Intern Med 148:551–553
Cron RQ, Swetter SM (1994) Scleredema revisited. A poststreptococcal complication. Clin Pediatr (Phila) 33:606–610
Angeli-Besson C, Koeppel MC, Jacquet P, Andrac L, Sayag J (1994) Electron-beam therapy in scleredema adultorum with associated monoclonal hypergammaglobulinaemia. Br J Dermatol 130:394–397
Chang HK, Kim YC, Kwon BS (2004) Widespread scleredema accompanied with a monoclonal gammopathy in a patient with advanced ankylosing spondylitis. J Korean Med Sci 19:481–483
Szturz P, Adam Z, Vasku V et al (2013) Complete remission of multiple myeloma associated scleredema after bortezomib-based treatment. Leuk Lymphoma 54:1324–1326
Dziadzio M, Anastassiades CP, Hawkins PN et al (2006) From scleredema to AL amyloidosis: disease progression or coincidence? Review of the literature. Clin Rheumatol 25:3–15
Krakowski A, Covo J, Berlin C (1973) Diabetic scleredema. Dermatologica 146:193–198
Fabri M, Hunzelmann N (2007) Differential diagnosis of scleroderma and pseudoscleroderma. J Dtsch Dermatol Ges 5:977–984
Miguel D, Schliemann S, Elsner P (2018) Treatment of Scleroedema Adultorum Buschke: A Systematic Review. Acta Derm Venereol 98:305–309
Kreuter A, Krieg T, Worm M et al (2016) German guidelines for the diagnosis and therapy of localized scleroderma. J Dtsch Dermatol Ges 14:199–216
Kroft EB, Berkhof NJ, van de Kerkhof PC et al (2008) Ultraviolet A phototherapy for sclerotic skin diseases: a systematic review. J Am Acad Dermatol 59:1017–1030
Kreuter A, Breuckmann F, Uhle A et al (2004) Low-dose UVA1 phototherapy in systemic sclerosis: effects on acrosclerosis. J Am Acad Dermatol 50:740–747
Tuchinda C, Kerr HA, Taylor CR et al (2006) UVA1 phototherapy for cutaneous diseases: an experience of 92 cases in the United States. Photodermatol Photoimmunol Photomed 22:247–253
Eberlein-König B, Vogel M, Katzer K et al (2005) Successful UVA1 phototherapy in a patient with scleredema adultorum. J Eur Acad Dermatol Venereol 9:203–204
Janiga JJ, Ward DH, Lim HW (2004) UVA-1 as a treatment for scleredema. Photodermatol Photoimmunol Photomed 20:210–211
Thumpimukvatana N, Wongpraparut C, Lim HW (2010) Scleredema diabeticorum successfully treated with ultraviolet A1 phototherapy. J Dermatol 37:1036–1039
Kochs C, Bockmann A, Hanneken S, Neumann NJ (2011) Scleredema diabeticorum: successful treatment with UVA-1 phototherapy. Hautarzt 62:255–257
Rongioletti F, Kaiser F, Cinotti E et al (2015) Scleredema. A multicentre study of characteristics, comorbidities, course and therapy in 44 patients. J Eur Acad Dermatol Venereol 29:2399–2404
Hager CM, Sobhi HA, Hunzelmann N et al (1998) Bath-PUVA therapy in three patients with scleredema adultorum. J Am Acad Dermatol 38:240–242
Grundmann-Kollmann M, Ochsendorf F, Zollner TM et al (2000) Cream PUVA therapy for scleredema adultorum. Br J Dermatol 142:1058–1059
Nakajima K, Iwagaki M, Ikeda M, Kodama H (2006) Two cases of diabetic scleredema that responded to PUVA therapy. J Dermatol 33:820–822
Lewerenz V, Ruzicka T (2007) Scleredema adultorum associated with type 2 diabetes mellitus: a report of three cases. J Eur Acad Dermatol Venereol 21:560–561
Kokpol C, Rajatanavin N, Rattanakemakorn P (2012) Successful Treatment of Scleredema Diabeticorum by Combining Local PUVA and Colchicine: A Case Report. Case Rep Dermatol 4:265–268
Yüksek J, Sezer E, Köseoğlu D, Markoç F, Yıldız H (2010) Scleredema treated with broad-band ultraviolet A phototherapy plus colchicine. Photodermatol Photoimmunol Photomed 26:257–260
Xiao T, Yang ZH, He CD, Chen HD (2007) Scleredema adultorum treated with narrow-band ultraviolet B phototherapy. J Dermatol 34:270–272
Yoshimura J, Asano Y, Takahashi T et al (2016) A case of scleredema adultorum successfully treated with narrow-band ultraviolet B phototherapy. Mod Rheumatol 26:302–306
Tamburin LM, Pena JR, Meredith R, Soong VY (1998) Scleredema of Buschke successfully treated with electron beam therapy. Arch Dermatol 134:419–422
Bowen AR, Smith L, Zone JJ (2003) Scleredema adultorum of Buschke treated with radiation. Arch Dermatol 139:780–784
Könemann S, Hesselmann S, Bölling T et al (2004) Radiotherapy of benign diseases-scleredema adultorum Buschke. Strahlenther Onkol 180:811–814
Angeli-Besson C, Koeppel MC, Jacquet P et al (1994) Electron-beam therapy in scleredema adultorum with associated monoclonal hypergammaglobulinaemia. Br J Dermatol 130:394–397
Stables GI, Taylor PC, Highet AS (2000) Scleredema associated with paraproteinaemia treated by extracorporeal photopheresis. Br J Dermatol 142:781–783
Knobler R, Moinzadeh P, Hunzelmann N et al (2017) European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes. J Eur Acad Dermatol Venereol 31:1401–1424
Dogramaci AC, Inan MU, Atik E, Gokce C (2012) Scleredema diabeticorum partially treated with low-dose methotrexate: a report of five cases. Balkan Med J 29:218–221
Breuckmann F, Appelhans C, Harati A et al (2005) Failure of low-dose methotrexate in the treatment of scleredema diabeticorum in seven cases. Dermatology 211:299–301
Mattheou-Vakali G, Ioannides D, Thomas T et al (1996) Cyclosporine in scleredema. J Am Acad Dermatol 35:990–991
Salisbury JA, Shallcross H, Leigh IM (1988) Scleredema of Buschke associated with multiple myeloma. Clin Exp Dermatol 13:269–270
Aichelburg MC, Loewe R, Schicher N et al (2012) Successful treatment of poststreptococcal scleredema adultorum Buschke with intravenous immunoglobulins. Arch Dermatol 148:1126–1128
Venturi C, Zendri E, Santini M et al (2004) Scleredema of Buschke: remission with factor XIII treatment. Int J Tissue React 26:25–28
Ikeda Y, Suehiro T, Abe T et al (1998) Severe diabetic scleredema with extension to the extremities and effective treatment using prostaglandin E1. Intern Med 37:861–864
Lee FY, Chiu HY, Chiu HC (2011) Treatment of acquired reactive perforating collagenosis with allopurinol incidentally improves scleredema diabeticorum. J Am Acad Dermatol 65:e115–e117
Alsaeedi SH, Lee P (2010) Treatment of scleredema diabeticorum with tamoxifen. J Rheumatol 37:2636–2637
Szturz P, Adam Z, Vašků V et al (2013) Complete remission of multiple myeloma associated scleredema after bortezomib-based treatment. Leuk Lymphoma 54:1324–1326
Dezoteux F, Bourges M, Lionet A, Carpentier O (2018) Buschke’s scleredema successfully treated with extracorporeal photopheresis. Rev Med Interne 39:360–363
Bray SM, Varghese S, English JC 3rd (2010) Ultrasonic massage and physical therapy for scleredema: improving activities of daily living. Arch Dermatol 146:453–454
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
A. Kreuter gibt an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine vom Autor durchgeführten Studien an Menschen oder Tieren. Alle Patienten, die über Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts zu identifizieren sind, haben hierzu ihre schriftliche Einwilligung gegeben. Im Falle von nicht mündigen Patienten liegt die Einwilligung eines Erziehungsberechtigten oder des gesetzlich bestellten Betreuers vor.
Rights and permissions
About this article
Cite this article
Kreuter, A. Scleroedema adultorum. Hautarzt 69, 908–915 (2018). https://doi.org/10.1007/s00105-018-4259-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00105-018-4259-6